Korro Bio has received clearance from the Australian regulatory body to initiate a Phase 1/2 trial of its RNA-editing therapeutic candiate KRRO-110 in...

Intellia Therapeutics announced yesterday that the UK’s Medicine and Healthcare products Regulatory Agency has cleared its clinical trial application...

In this clinical update, we bring you the latest news from four gene-editing trials sponsored by Beam Therapeutics, Intellia Therapeutics, Editas...